ANDA 206694, held by Zydus Pharms. Tamoxifen Citrate.
As of Nov 15, 2026, ANDA 206694 (Tamoxifen Citrate), held by Zydus Pharms, was first approved by FDA on Oct 27, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 27, 2017 | Original application | Approved | None posted |
| Tamoxifen CitrateEQ 10MG BASE · tablet;oral | Tamoxifen Citrate | Rx |
| Tamoxifen CitrateEQ 20MG BASE · tablet;oral | Tamoxifen Citrate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
